Urokinase is a type of enzyme that functions as a plasminogen activator,
which hydrolyzes plasminogen to form plasmin. Urokinase is commonly used for
treating acute ischemic stroke, pulmonary embolism, and arterial thrombosis, and
it is also used during extracorporeal circulation and as a fibrinolytic agent
As an active pharmaceutical ingredient (API), urokinase must meet strict
quality standards and guidelines set by international regulatory agencies. These
guidelines ensure that the urokinase used in pharmaceutical products is safe,
effective and of high quality.
There are several reliable suppliers of urokinase API globally. These
suppliers have a track record of providing high quality urokinase API that meets
the strictest quality standards. Some common suppliers of urokinase API include
Hualan Biological Engineering Inc., Wuhan Wuyao Pharmaceutical Co. Ltd, and
Jiangsu Aidea Pharmaceutical Co. Ltd.
When selecting a urokinase API supplier, it is important to consider
factors such as quality, reliability, cost-effectiveness, and timely delivery.
It is also important to choose a supplier with a solid reputation in the
industry to ensure that the product is up to the required standards.
In conclusion, urokinase API is a crucial pharmaceutical ingredient used in
many lifesaving drugs. Selecting a reliable supplier is essential to ensure the
product's quality, safety and efficacy. By partnering with a reputable supplier,
pharmaceutical companies can help ensure the success of their products and the
well-being of their patients.